Susquehanna International Group’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Buy |
143,945
+14,210
| +11% | +$299K | ﹤0.01% | 1813 |
|
|
2025
Q1 | $2.13M | Buy |
129,735
+79,108
| +156% | +$1.3M | ﹤0.01% | 2214 |
|
|
2024
Q4 | $1.3M | Buy |
50,627
+15,571
| +44% | +$400K | ﹤0.01% | 2608 |
|
|
2024
Q3 | $1.11M | Buy |
35,056
+5,501
| +19% | +$174K | ﹤0.01% | 2547 |
|
|
2024
Q2 | $1.04M | Sell |
29,555
-8,054
| -21% | -$283K | ﹤0.01% | 2511 |
|
|
2024
Q1 | $1.65M | Buy |
37,609
+6,907
| +22% | +$303K | ﹤0.01% | 2042 |
|
|
2023
Q4 | $1.09M | Buy |
30,702
+11,370
| +59% | +$405K | ﹤0.01% | 2740 |
|
|
2023
Q3 | $522K | Sell |
19,332
-17,763
| -48% | -$479K | ﹤0.01% | 3358 |
|
|
2023
Q2 | $872K | Sell |
37,095
-26,808
| -42% | -$630K | ﹤0.01% | 2914 |
|
|
2023
Q1 | $877K | Buy |
63,903
+51,289
| +407% | +$704K | ﹤0.01% | 3085 |
|
|
2022
Q4 | $229K | Sell |
12,614
-30,659
| -71% | -$557K | ﹤0.01% | 4282 |
|
|
2022
Q3 | $646K | Buy |
43,273
+9,330
| +27% | +$139K | ﹤0.01% | 3158 |
|
|
2022
Q2 | $468K | Buy |
33,943
+1,289
| +4% | +$17.8K | ﹤0.01% | 3432 |
|
|
2022
Q1 | $365K | Sell |
32,654
-8,849
| -21% | -$98.9K | ﹤0.01% | 4104 |
|
|
2021
Q4 | $981K | Buy |
41,503
+24,688
| +147% | +$584K | ﹤0.01% | 2890 |
|
|
2021
Q3 | $429K | Buy |
+16,815
| New | +$429K | ﹤0.01% | 3892 |
|
|
2021
Q2 | – | Sell |
-10,739
| Closed | -$252K | – | 5595 |
|
|
2021
Q1 | $252K | Buy |
10,739
+202
| +2% | +$4.74K | ﹤0.01% | 4552 |
|
|
2020
Q4 | $148K | Sell |
10,537
-6,421
| -38% | -$90.2K | ﹤0.01% | 4377 |
|
|
2020
Q3 | $213K | Buy |
+16,958
| New | +$213K | ﹤0.01% | 3847 |
|
|
2020
Q2 | – | Sell |
-19,240
| Closed | -$79K | – | 4537 |
|
|
2020
Q1 | $79K | Buy |
19,240
+6,502
| +51% | +$26.7K | ﹤0.01% | 4100 |
|
|
2019
Q4 | $96K | Buy |
+12,738
| New | +$96K | ﹤0.01% | 3679 |
|